​

Funding Round

Post-IPO Equity - SomaLogic

Post-IPO Equity - SomaLogic

Investment Firm

Overview

SomaLogic is a protein biomarker discovery and clinical diagnostics company, offers SOMAmer technology to improve diagnostic products.

Announced Date

Sep 01, 2021

Funding Type

Post Ipo Equity

Highlights

Location

United States, North America

Social

Investor Lead

N/A

Participant Investors

8

Investor Name
Participant InvestorCounterpoint Global
Participant InvestorPerceptive Advisors
Participant InvestorIllumina
Participant InvestorT. Rowe Price
Participant InvestorFarallon Capital Management

Round Details and Background

SomaLogic raised $375000000 on 2021-09-01 in Post-IPO Equity

SomaLogic is a protein biomarker discovery and clinical diagnostics company, offers SOMAmer technology to improve diagnostic products.

Company Funding History

17

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Jun 04, 2014
Grant - SomaLogic
1-1.0M
Aug 20, 2010
Venture Round - SomaLogic
-5.0M
Nov 17, 2010
Series A - SomaLogic
-15.0M
Aug 21, 2013
Venture Round - SomaLogic
-10.0M

Recent Activity

There is no recent news or activity for this profile.